Active ingredientAtogepantCat. No. P-A208-001CAS 1374248-81-3Family · Pharmaceutical analytical standards
Atogepant
A gepant, that is an oral antagonist of the receptor for CGRP, a key molecule in migraine attacks: it is taken every day to prevent them. Approved in the United States in September 2021 and in the European Union in August 2023. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?CGRP was discovered by chance in the early 1980s by researchers studying thyroid tumours: it is made from the same gene as calcitonin, hence the name "calcitonin gene-related peptide".
Go to the active ingredient →Active ingredientAtogepantCat. No. P-A208-001CAS 1374248-81-3
Isotopically labelledAtogepant-d4Cat. No. P-A208-002
ImpurityAtogepant Impurity 1Cat. No. P-A208-003CAS 1456803-42-1
ImpurityAtogepant Impurity 2Cat. No. P-A208-004
ImpurityAtogepant Impurity 3 (Atogepant Enantiomer)Cat. No. P-A208-005CAS 2733814-47-4
ImpurityAtogepant Impurity 4Cat. No. P-A208-006
ImpurityAtogepant Impurity 5Cat. No. P-A208-007
ImpurityAtogepant Impurity 6Cat. No. P-A208-008CAS 1488326-89-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.